Assyro AI

FDA Orange Book · active-ingredient family

Methyldopa

Methyldopa is approved as 3 brand and 43 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.

Reference-listed drug:ALDOMET · NDA 013400

3

Brand (NDA)

43

Generics (ANDA)

0

Listed patents

0

Exclusivity periods

Brand (NDA) products · suspension, tablet

ProductApplicantApplicationTEApproved
ALDOMETRLD×3MERCKNDA 013400Approved Prior to Jan 1, 1982
METHYLDOPA×2CHARTWELL RXNDA 018934Jun 29, 1984
ALDOMETMERCKNDA 018389Approved Prior to Jan 1, 1982

Generic (ANDA) products (43)

ProductApplicantApplicationTEApproved
METHYLDOPASUPERPHARMANDA 070669Jun 23, 1989
METHYLDOPASUPERPHARMANDA 070670Jun 23, 1989
METHYLDOPAPLIVAANDA 072126Jul 07, 1988
METHYLDOPAPLIVAANDA 072127Jul 07, 1988
METHYLDOPAPLIVAANDA 072128Jul 07, 1988
METHYLDOPAHALSEYANDA 071751Mar 28, 1988
METHYLDOPAHALSEYANDA 071752Mar 28, 1988
METHYLDOPAHALSEYANDA 071753Mar 28, 1988
METHYLDOPACHARTWELL RXANDA 071700Mar 02, 1988
METHYLDOPAQUAGENANDA 070535Jan 02, 1987
METHYLDOPAQUAGENANDA 070536Jan 02, 1987
METHYLDOPAQUAGENANDA 070537Jan 02, 1987
METHYLDOPADURAMED PHARMS BARRANDA 071006Dec 16, 1986
METHYLDOPADURAMED PHARMS BARRANDA 071009Dec 16, 1986
METHYLDOPATEVAANDA 071105Dec 05, 1986
METHYLDOPATEVAANDA 071106Dec 05, 1986
METHYLDOPATEVAANDA 071067Dec 05, 1986
METHYLDOPASUN PHARM INDUSTRIESANDA 070073Oct 09, 1986
METHYLDOPASUN PHARM INDUSTRIESANDA 070060Oct 09, 1986
METHYLDOPASUN PHARM INDUSTRIESANDA 070074Oct 09, 1986
METHYLDOPAWATSON LABSANDA 070703Jun 06, 1986
METHYLDOPAWATSON LABSANDA 070625Jun 06, 1986
METHYLDOPAROXANEANDA 070192Apr 25, 1986
METHYLDOPAROXANEANDA 070193Apr 25, 1986
METHYLDOPAROXANEANDA 070194Apr 25, 1986
METHYLDOPAPARKE DAVISANDA 070331Apr 15, 1986
METHYLDOPAPARKE DAVISANDA 070332Apr 15, 1986
METHYLDOPAPARKE DAVISANDA 070333Apr 15, 1986
METHYLDOPAWATSON LABSANDA 070245Feb 25, 1986
METHYLDOPAWATSON LABSANDA 070246Feb 25, 1986
METHYLDOPAWATSON LABSANDA 070247Feb 25, 1986
METHYLDOPAHERITAGE PHARMAANDA 070098Feb 20, 1986
METHYLDOPAHERITAGE PHARMAANDA 070343Feb 20, 1986
METHYLDOPAPUREPAC PHARMANDA 070749Feb 07, 1986
METHYLDOPAPUREPAC PHARMANDA 070750Feb 07, 1986
METHYLDOPAPUREPAC PHARMANDA 070452Feb 07, 1986
METHYLDOPAACCORD HLTHCAREANDA 070070Oct 15, 1985
METHYLDOPAACCORD HLTHCAREANDA 070084Oct 15, 1985
METHYLDOPAACCORD HLTHCAREANDA 070085Oct 15, 1985
METHYLDOPAWATSON LABSANDA 070260Jun 24, 1985
METHYLDOPAWATSON LABSANDA 070261Jun 24, 1985
METHYLDOPAWATSON LABSANDA 070262Jun 24, 1985
METHYLDOPA×2RISINGANDA 070076Apr 18, 1985

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Methyldopa — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.